Adage Capital Partners Gp, L.L.C. Edgewise Therapeutics, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51.6 Billion
- Q1 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 390,000 shares of EWTX stock, worth $5.44 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
390,000
Previous 240,000
62.5%
Holding current value
$5.44 Million
Previous $6.41 Million
33.9%
% of portfolio
0.02%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding EWTX
# of Institutions
220Shares Held
105MCall Options Held
2.57MPut Options Held
1.58M-
Orbimed Advisors LLC San Diego, CA15MShares$210 Million10.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$124 Million4.07% of portfolio
-
Perceptive Advisors LLC New York, NY6.55MShares$91.3 Million6.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$85.9 Million1.61% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$83.9 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $881M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...